3648 results for «2576»

Filter By

3648 results

Optimal timing of aspirin discontinuation: when early is too early?

20 May 2026 – From EuroPCR 2026

This session critically evaluates the optimal timing for aspirin discontinuation after PCI, discussing outcomes of aspirin-free strategies initiated within one month versus three months post-procedure. It considers differential effects of DAPT duration based on ACS presentation and bleeding risk, supported by meta-analyses and real-world data to...

Bifurcation PCI with complications - Part 1

20 May 2026 – From EuroPCR 2026

This session addresses complications encountered during bifurcation PCI through real-world cases involving stent dislodgement, entrapped guidewires, failed wiring techniques, and fractured devices. It highlights technical rescue maneuvers, the role of intravascular imaging, and long-term challenges encountered in managing complex bifurcation lesions to improve procedural success and...

New devices for structural interventions

20 May 2026 – From EuroPCR 2026

Explore the latest advancements in structural interventions with a focus on novel devices and their early clinical outcomes. This session reviews cutting-edge technologies including balloon-expandable TAVI, percutaneous mechanical aspiration for infective endocarditis, and emerging transcatheter tricuspid valve replacement systems, alongside multicenter evaluations of TEER devices in...

New devices for structural interventions

The digital pulse: innovation in the cathlab

20 May 2026 – From EuroPCR 2026

This session highlights transformative innovations in the catheterization laboratory that prioritize patient-centered care and enhanced safety. Focus areas include advancements in radiation practice through new technology and the integration of artificial intelligence to improve image analysis, decision-making, and procedural efficiency in interventional cardiology.

Complex transfemoral TAVI: how to manage the root to success

20 May 2026 – From EuroPCR 2026

Addressing the challenges of complex transfemoral TAVI, this session provides expert guidance on managing difficult vascular access routes to ensure procedural success. Topics include advanced techniques for straightening pathways, managing hostile access, and innovative strategies for contrast-zero TAVI in challenging anatomies.

New strategies in STEMI treatments

20 May 2026 – From EuroPCR 2026

Investigate new strategies in STEMI treatment through data from international registries and clinical trials. This session examines the comparative efficacy of sirolimus versus paclitaxel-coated balloons, plaque modification in calcified lesions, novel cardioprotective techniques during primary PCI, and the role of AI-assisted ECG interpretation in STEMI pathways.

Debate: how will AI change the cardiology landscape in the next five years?

20 May 2026 – From EuroPCR 2026

Delve into the anticipated impact of artificial intelligence on cardiology over the next five years. This session addresses AI's role in reporting, triage, workflow optimization, and decision-making, while distinguishing realistic clinical benefits from hype. It also discusses governance, accountability, and legal considerations surrounding AI adoption in...

Large-bore thrombectomy in pulmonary embolism practice: when intervention matters

20 May 2026 – From EuroPCR 2026

Management of pulmonary embolism is increasingly shifting toward interventional strategies, where timing, patient selection and procedural expertise play a central role in improving outcomes.

Large-bore thrombectomy is examined as a key option within contemporary PE treatment, focusing on when intervention is most appropriate and how to optimise...

Large-bore thrombectomy in pulmonary embolism practice: when intervention matters

From angiography to precision PCI: integrating ACIST Pro contrast management system and high-definition IVUS imaging

21 May 2026 – From EuroPCR 2026

This EuroPCR 2026 session explores how advanced imaging and contrast management technologies can support a more precise and reproducible PCI workflow. The discussion focuses on the integration of the ACIST Pro contrast management system with high-definition intravascular ultrasound (IVUS) imaging to improve angiographic consistency, optimise contrast...

From angiography to precision PCI: integrating ACIST Pro contrast management system and high-definition IVUS imaging

STEMI 2026 - The precision revolution

19 May 2026 – From EuroPCR 2026

Explore the forefront of STEMI care with a focus on precision medicine, integrating artificial intelligence for pre-hospital triage, evidence-based complete revascularisation strategies, and advanced imaging guidance during primary PCI. This session also addresses tailored antithrombotic approaches, timing of mechanical support in cardiogenic shock, and management of...

Simplify the complex with Shockwave C2 Aero - Next-generation coronary intravascular lithotripsy that delivers

21 May 2026 – From EuroPCR 2026

This EuroPCR 2026 session highlights the role of the next-generation Shockwave C2 Aero coronary intravascular lithotripsy system in the treatment of complex calcified coronary artery disease. Supported by real-world clinical experience and recent evidence, the discussion focuses on procedural safety, lesion preparation, and treatment consistency in...

Simplify the complex with Shockwave C2 Aero - Next-generation coronary intravascular lithotripsy that delivers

Beyond the angiogram: contemporary management of STEMI

19 May 2026 – From EuroPCR 2026

This session provides an in-depth review of complex STEMI cases from diverse clinical settings, emphasizing optimisation of primary PCI strategies, complication management, and individualised antithrombotic therapy. Real-world cases from Albania, Macedonia, and Slovakia illustrate diagnostic challenges and therapeutic decision-making to improve patient outcomes.

The right therapy for right heart failure and tricuspid regurgitation: fixing my patient congestion, not just a valve

21 May 2026 – From EuroPCR 2026

This EuroPCR 2026 session shifts the focus in tricuspid regurgitation from anatomy alone to the broader context of right heart failure and systemic congestion. It highlights the limitations of purely leaflet-based strategies, particularly in advanced disease and in the presence of severe right ventricular dysfunction.

The discussion...

The right therapy for right heart failure and tricuspid regurgitation: fixing my patient congestion, not just a valve

Aortic regurgitation in 2026

21 May 2026 – From EuroPCR 2026

Get a comprehensive overview of contemporary management strategies for aortic regurgitation, a condition that remains frequently underdiagnosed and undertreated despite significant advances in transcatheter therapies thanks to this EuroPCR 2026 session.

The programme reviews current diagnostic and treatment pathways, including guideline-based management and the role of surgical...

Aortic regurgitation in 2026

LDL-C management: should it begin in the cathlab?

21 May 2026 – From EuroPCR 2026

This EuroPCR 2026 session examines the evolving role of LDL cholesterol management in patients undergoing percutaneous coronary intervention (PCI), with a focus on the potential benefits of initiating intensive lipid-lowering strategies early in the patient pathway.

The discussion reviews emerging evidence on PCSK9 inhibition in elective PCI...

LDL-C management: should it begin in the cathlab?

Active unloading with Impella heart pumps in elective and emergent patients

21 May 2026 – From EuroPCR 2026

This session presents the latest evidence on the use of microaxial Impella heart pumps in both elective high-risk and emergent cardiogenic shock patients. It highlights the importance of organised systems of care in improving survival outcomes and explores current data and expert consensus on mechanical circulatory...

Active unloading with Impella heart pumps in elective and emergent patients

TAVI complications and management strategies

19 May 2026 – From EuroPCR 2026

Gain comprehensive knowledge on anticipating, identifying, and managing complications during transcatheter aortic valve implantation (TAVI). Through complex international case studies—including transaxillary Navitor implantation and bicuspid aortic valve challenges—this session highlights key strategies to improve procedural safety and outcomes.

Ascending into the future with drug-coated balloons

21 May 2026 – From EuroPCR 2026

Step into the future of interventional cardiology with comprehensive insights into drug‑coated balloons (DCB). This session covers the new DCB ARC guidelines, previews findings from the impactful BASKET BALL randomised trial, and examines real-world evidence from the SCORE registry. It also addresses the optimisation of acute...

Ascending into future with drug-coated balloons

IVUS and NIRS imaging: a pathway to improve outcomes in stable and acute coronary syndromes

19 May 2026 – From EuroPCR 2026

IVUS-guided PCI is well established in complex coronary interventions, but combining it with near-infrared spectroscopy (NIRS) is opening a new dimension by linking vessel geometry with plaque biology.

This EuroPCR 2026session explores how IVUS-NIRS imaging improves PCI planning and risk stratification in both stable and acute coronary...

IVUS and NIRS imaging: a pathway to improve outcomes in stable and acute coronary syndromes

Managing life-threatening TAVI complications

19 May 2026 – From EuroPCR 2026

Manage life-threatening complications in TAVI procedures with a structured algorithm for identification and resolution. This session shares expert tips for handling specific severe complications and reviews best practices aimed at complication avoidance to enhance patient safety and procedural success.

Managing life-threatening TAVI complications
Didn’t find what you were looking for?